DOP2003000728A - TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENETIVE DISORDERS - Google Patents

TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENETIVE DISORDERS

Info

Publication number
DOP2003000728A
DOP2003000728A DO2003000728A DO2003000728A DOP2003000728A DO P2003000728 A DOP2003000728 A DO P2003000728A DO 2003000728 A DO2003000728 A DO 2003000728A DO 2003000728 A DO2003000728 A DO 2003000728A DO P2003000728 A DOP2003000728 A DO P2003000728A
Authority
DO
Dominican Republic
Prior art keywords
compounds
tiazol
neurodegenetive
disorders
treatment
Prior art date
Application number
DO2003000728A
Other languages
Spanish (es)
Inventor
Yuhpyng Liang Chen
Michael Leon Corman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to DO2003000728A priority Critical patent/DOP2003000728A/en
Publication of DOP2003000728A publication Critical patent/DOP2003000728A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE TRATA DE COMPUESTOS DE TIAZOL QUE INHIBEN LA PRODUCCION DE ALFABETA-PEPTIDOS. PROPORCIONA ADEMAS COMPOSICIONES FARMACEUTICAS Y METODOS QUE USAN ESTOS COMPUESTOS PARA TRATAR ENFERMEDADES COMO LA DE ALZHEIMERIT IS TIAZOL COMPOUNDS THAT INHIBIT ALPHABET-PEPTIDES PRODUCTION. ALSO PROVIDES PHARMACEUTICAL COMPOSITIONS AND METHODS THAT USE THESE COMPOUNDS TO TREAT DISEASES LIKE ALZHEIMER'S

DO2003000728A 2003-10-06 2003-10-06 TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENETIVE DISORDERS DOP2003000728A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2003000728A DOP2003000728A (en) 2003-10-06 2003-10-06 TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENETIVE DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2003000728A DOP2003000728A (en) 2003-10-06 2003-10-06 TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENETIVE DISORDERS

Publications (1)

Publication Number Publication Date
DOP2003000728A true DOP2003000728A (en) 2004-04-15

Family

ID=44261238

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2003000728A DOP2003000728A (en) 2003-10-06 2003-10-06 TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENETIVE DISORDERS

Country Status (1)

Country Link
DO (1) DOP2003000728A (en)

Similar Documents

Publication Publication Date Title
ECSP055719A (en) TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
ATE396973T1 (en) BENZYL ETHER AND BENZYLAMINO BETA SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
NO20060278L (en) Piperazine derivatives and methods of use
ATE544748T1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CELL PROLIFERATION DISEASES
GT200500060A (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
EP1841426A4 (en) Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease
EA200700909A1 (en) AZAINDOLKARBOXAMIDES
ECSP088969A (en) AMINO-IMIDAZOLONES AND ITS USE AS A MEDICINAL PRODUCT TO TREAT COGNITIVE DEFICIENCIES, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA
EA200701296A1 (en) 3,5-Disposable and 3,5,7-triple-substituted 3H-oxazolo-and 3H-thiazolo [4,5-D] pyrimidin-2-she and their medicines
MXPA03011484A (en) Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease.
BR0316350A (en) Diaminotriazoles useful as protein kinase inhibitors
TW200724543A (en) Heterocyclic compounds and their uses as therapeutic agents
DOP2007000053A (en) TETRAHYDROPIRIDOTIENOPIRIMIDINA COMPOUNDS AND METHODS FOR USE
UY27872A1 (en) CASPASA INHIBITORS AND USES OF THE SAME.
EA200601212A1 (en) PHOSPHODESTERASE INHIBITORS, OBTAINING AND THEIR THERAPEUTIC APPLICATION
ATE538651T1 (en) SPIROPIPERIDINE INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
CY1108932T1 (en) Compounds 4- (heterocyclyl) -benzenesulfoximine for the therapeutic treatment of inflammatory diseases
TNSN06403A1 (en) 3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
EA200802020A1 (en) TETRAHYDROPYRIMIDAOZEPINA AND THEIR APPLICATION AS TRPV 1 MODULATORS
ATE390928T1 (en) COMPOSITIONS FOR TREATING SKIN DISEASES
BR0111140A (en) Polymorphic form, pharmaceutical composition, methods for treating an inflammatory disease, a cyclooxygenase-mediated disease, pain, and a process for making a polymorph v
EA200601607A1 (en) SULPHONAMIDE CONNECTIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
PA8603001A1 (en) USEFUL COMPOUNDS FOR THE TREATMENT OF DISEASES
PA8609801A1 (en) COMPOUNDS FOR THE TREATMENT OF NEUROGENERATIVE DISORDERS
TW200740808A (en) Inhibiteurs de proteines kinases